Cargando…

Comparative Effectiveness of Different Radical Radiotherapy Treatment Regimens for Prostate Cancer: A Population-Based Cohort Study

BACKGROUND: It is unclear which radiotherapy technique and dose fractionation scheme is most effective in decreasing the risk of prostate cancer death. METHODS: We conducted a population-based cohort study among 15 164 men in the Prostate Cancer database Sweden (version 4.0) treated with primary rad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pettersson, Andreas, Alm, Daniel, Garmo, Hans, Hjelm Eriksson, Marie, Castellanos, Enrique, Åström, Lennart, Kindblom, Jon, Widmark, Anders, Gunnlaugsson, Adalsteinn, Franck Lissbrant, Ingela, Nilsson, Per, Stattin, Pär
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192027/ https://www.ncbi.nlm.nih.gov/pubmed/32373776 http://dx.doi.org/10.1093/jncics/pkaa006

Ejemplares similares

Population-based study on use of chemotherapy in men with castration resistant prostate cancer
por: Lissbrant, Ingela Franck, et al.
Publicado: (2013)

Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study
por: Fridriksson, Jón Ö., et al.
Publicado: (2016)

The Value of Real-World Data in Understanding Prostate Cancer Risk and Improving Clinical Care: Examples from Swedish Registries
por: Beckmann, Kerri, et al.
Publicado: (2021)

Observational study on time on treatment with abiraterone and enzalutamide
por: Fallara, Giuseppe, et al.
Publicado: (2020)

Population‐based study of long‐term functional outcomes after prostate cancer treatment
por: Carlsson, Sigrid, et al.
Publicado: (2015)

Public online reporting from a nationwide population‐based clinical prostate cancer register
por: Stattin, Pär, et al.
Publicado: (2018)

Change in prostate volume during extreme hypo-fractionation analysed with MRI
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2014)

Mini Review on the Use of Clinical Cancer Registers for Prostate Cancer: The National Prostate Cancer Register (NPCR) of Sweden
por: Cazzaniga, Walter, et al.
Publicado: (2019)

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base—a refined prostate cancer trajectory
por: Van Hemelrijck, Mieke, et al.
Publicado: (2016)

Temporal changes in cause‐specific death in men with localised prostate cancer treated with radical prostatectomy: a population‐based, nationwide study
por: Thomsen, Frederik B., et al.
Publicado: (2021)

The effect of prostate motion during hypofractionated radiotherapy can be reduced by using flattening filter free beams
por: Benedek, Hunor, et al.
Publicado: (2018)

The effect on the small bowel of 5-FU and oxaliplatin in combination with radiation using a microcolony survival assay
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2009)

Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer: A Dose-Response Study
por: Rasmusson, Elisabeth, et al.
Publicado: (2020)

A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and (68)Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2022)

PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2020)

Target definition in radiotherapy of prostate cancer using magnetic resonance imaging only workflow
por: Gunnlaugsson, Adalsteinn, et al.
Publicado: (2019)

5-α reductase inhibitors, benign prostatic hyperplasia, and risk of male breast cancer
por: Robinson, David, et al.
Publicado: (2015)

Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study
por: Robinson, David, et al.
Publicado: (2015)

Prescription-based prediction of baseline mortality risk among older men
por: Gedeborg, Rolf, et al.
Publicado: (2020)

Low rate of lymphedema after extended pelvic lymphadenectomy followed by pelvic irradiation of node-positive prostate cancer
por: Rasmusson, Elisabeth, et al.
Publicado: (2013)

Single institution followed by national implementation of systematic surgical quality control and feedback for radical prostatectomy: a 20-year journey
por: Stranne, J., et al.
Publicado: (2019)

Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
por: Jóhannesson, Vilberg, et al.
Publicado: (2021)

Simulation model of disease incidence driven by diagnostic activity
por: Westerberg, Marcus, et al.
Publicado: (2020)

Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic
por: Gedeborg, Rolf, et al.
Publicado: (2021)

Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden
por: Balabanova, Yanina, et al.
Publicado: (2022)

Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden
por: Balabanova, Yanina, et al.
Publicado: (2022)

Extratumoral Heme Oxygenase-1 (HO-1) Expressing Macrophages Likely Promote Primary and Metastatic Prostate Tumor Growth
por: Halin Bergström, Sofia, et al.
Publicado: (2016)

How to model temporal changes in comorbidity for cancer patients using prospective cohort data
por: Lindhagen, Lars, et al.
Publicado: (2015)

How to measure temporal changes in care pathways for chronic diseases using health care registry data
por: Ventimiglia, Eugenio, et al.
Publicado: (2019)

A drug comorbidity index to predict mortality in men with castration resistant prostate cancer
por: Fallara, Giuseppe, et al.
Publicado: (2021)

MRI-only radiotherapy from an economic perspective: Can new techniques in prostate cancer treatment be cost saving?
por: Persson, Emilia, et al.
Publicado: (2022)

Using C‐Arm X‐ray images from marker insertion to confirm the gold fiducial marker identification in an MRI‐only prostate radiotherapy workflow
por: Gustafsson, Christian, et al.
Publicado: (2018)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
por: Johansson, Silvia, et al.
Publicado: (2012)

Comparison of Relative Survival and Cause-Specific Survival in Men With Prostate Cancer According to Age and Risk Category: A Nationwide, Population-Based Study
por: Orrason, Andri Wilberg, et al.
Publicado: (2021)

Long‐term adverse effects after retropubic and robot‐assisted radical prostatectomy. Nationwide, population‐based study
por: Fridriksson, Jón Örn, et al.
Publicado: (2017)

Patterns of recurrence in anal cancer: a detailed analysis
por: Nilsson, Martin P., et al.
Publicado: (2020)

Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study
por: Robinson, David, et al.
Publicado: (2013)

A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0
por: Russell, Beth, et al.
Publicado: (2018)

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
por: Bergengren, Oskar, et al.
Publicado: (2021)

Long-term Outcomes Among Men Undergoing Active Surveillance for Prostate Cancer in Sweden
por: Ventimiglia, Eugenio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rqgprr27g8mbpfp29tpi9t8ric